Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 136 for “"MAO-B"”.

  1. Oxidation of Tetrahydropyridines by MAO B Biomimetics: Mechanistic Studies

    … mechanism of oxidation by monoamine oxidase B (MAO B) has been debated for just as long. Proponents of the single electron transfer (SET) pathway of oxidation faced severe critiques in that the hypothesized radical intermediates arising from the SET pathway were never directly observed. Work …

    vt Repository record for Oxidation of Tetrahydropyridines by MAO B Biomimetics: Mechanistic Studies (opens in a new tab)

  2. The treatment of Parkinson's disease using MAO-B inhibitors

    … it will be important to revisit the benefits of MAO-B inhibitors once more advanced progression techniques are available.

    bu Repository record for The treatment of Parkinson's disease using MAO-B inhibitors (opens in a new tab)

  3. Platelet monoamine oxidase type B (MAO-B) activity in psychopathy

    Studies of platelet MAO-B activity have revealed a link between low platelet activity and psychiatric syndromes characterized by an inability to control impulses and to anticipate future consequences of behavior (Oreland, 1980; Gottfries, von Knorring, & Oreland, 1980). These characteristics are …

    ubc Repository record for Platelet monoamine oxidase type B (MAO-B) activity in psychopathy (opens in a new tab) Download PDF for Platelet monoamine oxidase type B (MAO-B) activity in psychopathy (opens in a new tab)

  4. Thrombozytäre MAO-B-Aktivität und plasmatische Tryptophankonzentration bei suizidalen psychiatrischen Patienten

    … die Überprüfung der Frage, ob die thrombozytäre MAO-B-Aktivität und plasmatische TRP-Konzentration bei suizidalen psychiatrischen Patienten verändert sind und ob diese Veränderungen auf die Suizidalität oder eher auf andere Einflußfaktoren wie Alter, Geschlecht, Ernährungsstatus und …

    fu-berlin Repository record for Thrombozytäre MAO-B-Aktivität und plasmatische Tryptophankonzentration bei suizidalen psychiatrischen Patienten (opens in a new tab)

  5. Σύνθεση τετραϋποκατεστημένων προπαργυλαμινών ως αναστολέων των MAO-A και MAO-B ενζύμων

    Οι προπαργυλαμίνες, λόγω της ιδιαίτερης δομής τους, αποτελούν χρήσιμες οργανικές ενώσεις, διότι μεταξύ άλλων έχουν βιολογική δράση και μπορούν να οδηγήσουν σε πληθώρα ετεροκυκλικών συστημάτων. Στην παρούσα διπλωματική εργασία, αρχικά αναλύεται η σημασία των προπαργυλαμινών, ο τρόπος σύνθεσης και οι …

    athens Repository record for Σύνθεση τετραϋποκατεστημένων προπαργυλαμινών ως αναστολέων των MAO-A και MAO-B ενζύμων (opens in a new tab)

  6. MAO-B inhibitors protect against lipopolysaccharide-mediated epithelial barrier loss and cytokine release

    … Treatment of this model with monoamine oxidase (MAO) inhibitors ameliorated disease indices (Ekuni et al., 2009). This study employs an in vitro histiotypic model of epithelium to provide evidence that LPS-reduced epithelial barrier function associated with chronic inflammatory disease may be …

    ubc Repository record for MAO-B inhibitors protect against lipopolysaccharide-mediated epithelial barrier loss and cytokine release (opens in a new tab) Download PDF for MAO-B inhibitors protect against lipopolysaccharide-mediated epithelial barrier loss and cytokine release (opens in a new tab)

  7. Downregulation of lipopolysaccharide-induced intestinal epithelial cell chemokine secretion by a novel MAO B inhibitor

    … bacteria. Enzyme monoamine oxidase B (MAO B) gene and protein expression was upregulated in diseased tissue of LPS-induced periodontal mucosal chronic inflammation in rat; MAO inhibition with phenelzine reduced signs of inflammation (Ekuni et al., 2009). Current MAO inhibitors are brain …

    ubc Repository record for Downregulation of lipopolysaccharide-induced intestinal epithelial cell chemokine secretion by a novel MAO B inhibitor (opens in a new tab) Download PDF for Downregulation of lipopolysaccharide-induced intestinal epithelial cell chemokine secretion by a novel MAO B inhibitor (opens in a new tab)

  8. The synthesis and evaluation of N-methyl-2-phenylmaleimide analogues as inhibitors of MAO-B

    … inhibitors of the enzyme monoamine oxidase B (MAO-B). The most potent analogue was 1-methyl-(4-trifluoromethylphenyl) pyrrole with an enzyme-inhibitor dissociation constant (K¡ value) of 1.30 µM. The least potent inhibitor was 1-methyl-3-phenylpyrrole with a K¡ value of 118 µM. Since …

    nwu-za Repository record for The synthesis and evaluation of N-methyl-2-phenylmaleimide analogues as inhibitors of MAO-B (opens in a new tab)

  9. INVESTIGATION INTO THE TOXICITY OF DOPAMINE THIOETHERS AND THE ANTI-INFLAMMATORY ACTIVITIES OF PULATIVE MAO-B INHIBITOR METABOLITES

    … the rationale for dopamine-boosting therapies. MAO-B inhibitors are a well-established therapy in conjunction with DOPA. Previously, our lab has discovered a series of selective nanomolar monoamine oxidase B (MAO-B) inhibitors. These inhibitors have been shown to possess neuroprotective …

    nus Repository record for INVESTIGATION INTO THE TOXICITY OF DOPAMINE THIOETHERS AND THE ANTI-INFLAMMATORY ACTIVITIES OF PULATIVE MAO-B INHIBITOR METABOLITES (opens in a new tab) Download file for INVESTIGATION INTO THE TOXICITY OF DOPAMINE THIOETHERS AND THE ANTI-INFLAMMATORY ACTIVITIES OF PULATIVE MAO-B INHIBITOR METABOLITES (opens in a new tab)

  10. Farmacogenética da levodopa na doença de Parkinson : estudo de polimorfismos nos genes da COMT, MAO-B e DAT

    … (catecol-orto-metiltransferase), íntron 13 da MAO-B (monoamina oxidase B), VNTR (“variable number tandem repeat”) de 40pb da região 3'UTR (“untranslated region”) do DAT (transportador de dopamina) e -839C>T da região promotora 5' do DAT. A COMT e a MAO-B são as duas rotas enzimáticas de …

    brazil-ufrgs Repository record for Farmacogenética da levodopa na doença de Parkinson : estudo de polimorfismos nos genes da COMT, MAO-B e DAT (opens in a new tab)

  11. Synthesis and biological evaluation of 6-substituted coumaranone derivatives and related compounds as monoamine oxidase inhibitors

    … the motor symptoms of PD. Monoamine oxidase B (MAO-B) is predominantly found in the striatum and is responsible for the oxidative metabolism of dopamine. The first-line treatment of PD is dopamine replacement therapy with levodopa, the metabolic precursor of dopamine. Rapid metabolism of …

    nwu-za Repository record for Synthesis and biological evaluation of 6-substituted coumaranone derivatives and related compounds as monoamine oxidase inhibitors (opens in a new tab)

  12. The synthesis and evaluation of benzosuberone derivatives as inhibitors of monoamine oxidase

    Monoamine oxidase (MAO) is responsible for the catabolism of neurotransmitters such as serotonin and dopamine in the central nervous system and peripheral tissues. MAO inhibitors such as selegiline play a vital part in the treatment of neurodegenerative diseases including Parkinson's disease (PD) …

    nwu-za Repository record for The synthesis and evaluation of benzosuberone derivatives as inhibitors of monoamine oxidase (opens in a new tab)

  13. The synthesis and evaluation of phthalimide analogues as inhibitors of monoamine oxidase B

    … is still unknown. Monoamine oxidase (MAO-B) inhibitors have been used in the treatment of PD. MAO-B is known to be involved in the catalytic oxidation of biogenic amines, a reaction which produces aldehydes and hydrogen peroxide as byproducts. Both these by-products can be toxic if not …

    nwu-za Repository record for The synthesis and evaluation of phthalimide analogues as inhibitors of monoamine oxidase B (opens in a new tab)

  14. The synthesis and evaluation of (E)-styrylisatin analogues as inhibitors of monoamine oxidase B

    Monoamine oxidase B (MAO-B) inhibitors are currently clinically used in the symptomatic treatment of Parkinson's disease (PO) and may also possess .neuroprotective activity. The irreversible MAO-'B inhibitor, (R)-deprenyl, .is commonly used in PO treatment, usually in combination with levodopa …

    nwu-za Repository record for The synthesis and evaluation of (E)-styrylisatin analogues as inhibitors of monoamine oxidase B (opens in a new tab)

  15. An investigation of indanone derivatives as inhibitors of monoamine oxidase

    MAO-A and MAO-B are two isoforms of mitochondrial monoamine oxidase (MAO) that are responsible for the deamination of various monoamine substrates. For example tyramine and dopamine are metabolised by both MAO isoforms. MAO-A specifically metabolises noradrenaline and serotonin, while MAO-B …

    nwu-za Repository record for An investigation of indanone derivatives as inhibitors of monoamine oxidase (opens in a new tab)

  16. Monoamine oxidase inhibition by novel quinolinones

    … In the brain, the enzyme, monoamine oxidase B (MAOB), An analysis of the Lineweaver-Burk plots indicated that 7-(3-bromobenzyloxy)-3,4-dihydro-2(1H)- quinolinone inhibits MAO-B with a Ki value of 2.7 nM. An analysis of the structure-activity relationships for MAO-B inhibition shows that …

    nwu-za Repository record for Monoamine oxidase inhibition by novel quinolinones (opens in a new tab)

  17. The monoamine oxidase inhibition properties of caffeine analogues containing saturated C–8 substituents

    … can be treated by inhibiting monoamine oxidase (MAO), specifically MAO-B, since this is a major enzyme involved in the catabolism of dopamine in the substantia nigra of the brain. Inhibition of MAO-B may conserve the dopamine supply in the brain and may therefore provide symptomatic relief for PD …

    nwu-za Repository record for The monoamine oxidase inhibition properties of caffeine analogues containing saturated C–8 substituents (opens in a new tab)

  18. Novel monoamine oxidase B inhibitor downregulation of lipopolysaccharide-induced pro-inflammatory cytokines

    … cell barrier disruption. Monoamine oxidase (MAO) B, a pro-oxidative enzyme, is induced in epithelial cells of a rat periodontal disease model and topical application of a known MAO inhibitor reduced disease (Ekuni et al., 2009). MAO B inhibitors also reduced TNFα secretion in epithelial cells …

    ubc Repository record for Novel monoamine oxidase B inhibitor downregulation of lipopolysaccharide-induced pro-inflammatory cytokines (opens in a new tab) Download PDF for Novel monoamine oxidase B inhibitor downregulation of lipopolysaccharide-induced pro-inflammatory cytokines (opens in a new tab)

  19. Novel sulfanyl– and sulfinylcaffeine analogues as inhibitors of monoamine oxidase

    … (L-Dopa), DA agonists and monoamine oxidase B (MAO-B) inhibitors. The MAOs are flavoproteins that are bound to the outer membrane of the mitochondria and catalyze the oxidative deamination of neurotransmitters such as serotonin (5-HT), noradrenaline (NA) and DA. Two isoforms occur, namely MAO-A …

    nwu-za Repository record for Novel sulfanyl– and sulfinylcaffeine analogues as inhibitors of monoamine oxidase (opens in a new tab)

  20. The preparation and evaluation of xanthinyl analogues as inhibitors of monoamine oxidase B

    Monoamine oxidase B (MAO-B) is a drug target for the treatment of neurodegenerative diseases such as Parkinson's disease. For example, the mechanism-based inactivator of MAO-B, (R)-deprenyl, is frequently used in combination with L-dopa as dopamine replacement therapy in Parkinson's disease. In …

    nwu-za Repository record for The preparation and evaluation of xanthinyl analogues as inhibitors of monoamine oxidase B (opens in a new tab)

Page 1 of 7